šĀ·Mar 2, 2017Industry
usa patent grants for imp321 in cancer
Publisher
I
Immutep
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Immutep
- Region
- Global
- Scope
- Industry
- Published
- March 2, 2017
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on immutep.com
Leave the platform to read the original full article on the publisher site.
Source: Immutep
Scope: Industry
Related coverage
More related coverage
Certara/3h ago
Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate
Certara/3h ago
Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification
<![CDATA[Intermountain Health Newsroom]]>/8h ago
Intermountain Health Primary Childrenās Hospital to Host Mountain West Stop of ā100 Cleft Portraitsā Tour ā Free National Traveling Art Exhibit Open to Public
<![CDATA[Intermountain Health Newsroom]]>/9h ago